Understanding Nejm Amboss

Let's dive into the details surrounding Nejm Amboss. In this episode of the Further, Faster Podcast, Christoph Klink sits down with Sievert Weiss, co-founder of

Key Takeaways about Nejm Amboss

  • This is the first video in my partnership with @NEJMgroup in which I summarize the latest research using my unique set of skills ...
  • In publications, the statistical significance of a study is usually expressed as the p-value. It's the result of a study that's interpretable ...
  • In this week's interview, Joseph Ross talks with us about the prevalence of guest-authorship and ghostwriting in the medical ...
  • This short Double Take video from the _New England Journal of Medicine_ emphasizes the importance of remaining vigilant in ...
  • This Double Take video from the New England Journal of Medicine describes the case of a man with persistent diffuse abdominal ...

Detailed Analysis of Nejm Amboss

Raja-Elie Abdulnour is the Chief Clinical Innovation Officer at Neue Studien verstehen – und endlich sicher in der Praxis anwenden Was bedeuten aktuelle Forschungsergebnisse wirklich ... Subscribe to

In this

That wraps up our extensive overview of Nejm Amboss.

Recent Articles

The “Second Brain” for Doctors: How AMBOSS Scaled to 1.5M+ Physicians | The Further, Faster Podcast

The “Second Brain” for Doctors: How AMBOSS Scaled to 1.5M+ Physicians | The Further, Faster Podcast

In this episode of the Further, Faster Podcast, Christoph Klink sits down with Sievert Weiss, co-founder of

June 14, 2026
NEJM Interview: Raja-Elie Abdulnour on the need for clinicians and AI systems to refrain from exp...

NEJM Interview: Raja-Elie Abdulnour on the need for clinicians and AI systems to refrain from exp...

Raja-Elie Abdulnour is the Chief Clinical Innovation Officer at

June 14, 2026
Online-Fortbildung: From Evidence to Impact | AMBOSS & NEJM Group

Online-Fortbildung: From Evidence to Impact | AMBOSS & NEJM Group

Neue Studien verstehen – und endlich sicher in der Praxis anwenden Was bedeuten aktuelle Forschungsergebnisse wirklich ...

June 14, 2026
AMBOSS for Clinicians | Dependable and Trustworthy Answers

AMBOSS for Clinicians | Dependable and Trustworthy Answers

Subscribe to

June 14, 2026
Topical Antisepsis | NEJM

Topical Antisepsis | NEJM

This is the first video in my partnership with @NEJMgroup in which I summarize the latest research using my unique set of skills ...

June 14, 2026
Medical Statistics - Part 11: The p-value

Medical Statistics - Part 11: The p-value

In publications, the statistical significance of a study is usually expressed as the p-value. It's the result of a study that's interpretable ...

June 14, 2026
Podcast 2: Interview with Dr. Joseph Ross of Mt. Sinai School of Medicine

Podcast 2: Interview with Dr. Joseph Ross of Mt. Sinai School of Medicine

In this week's interview, Joseph Ross talks with us about the prevalence of guest-authorship and ghostwriting in the medical ...

June 14, 2026
Medical Mystery Solved — Hard to Swallow | NEJM

Medical Mystery Solved — Hard to Swallow | NEJM

This short Double Take video from the _New England Journal of Medicine_ emphasizes the importance of remaining vigilant in ...

June 14, 2026
Medical Mystery Solved — Led Astray | NEJM

Medical Mystery Solved — Led Astray | NEJM

This Double Take video from the New England Journal of Medicine describes the case of a man with persistent diffuse abdominal ...

June 14, 2026
NEJM In Studio: The Complicated History of Race Adjustments in Medicine: Anemia

NEJM In Studio: The Complicated History of Race Adjustments in Medicine: Anemia

In this

June 14, 2026
NEJM Interview: David Jones on the disparate historical approaches to anemia diagnosis and their ...

NEJM Interview: David Jones on the disparate historical approaches to anemia diagnosis and their ...

Watch the

June 14, 2026
How to use AMBOSS for MD Students: Unlocking Success in In-House Exams and Step 1

How to use AMBOSS for MD Students: Unlocking Success in In-House Exams and Step 1

AMBOSS

June 14, 2026
NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

Did you miss the ESMO Congress 2024? Listen here:

June 14, 2026